A funding round has brought in $4 million for Arsenal Medical, which has developed a foam product designed to address acute hemorrhage as well as critical clinical conditions. The Watertown, Mass.-based company also is the maker of the AxioCore core-sheath microfiber and nanofiber technologies used in tissue regeneration and cell integration.

Related Summaries